AVE 33.3% 0.2¢ avecho biotechnology limited

is this company dormant?, page-7

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    I am hungry for information, especially re OXY, and the market has clearly lost patience.

    Have you spoken to the company recently? I agree that there should be more update information coming in respect to Oxy for all to benefit, but when I spoke to them fairly recently, the plan was to begin a short single-dose, followed by multi-dose trial in December, however, more likely if closer to Christmas that this would begin early January instead. Phase 3 trials still on track to begin 1st quarter 2012 but I wouldn't be surprised if it's pushed back to Q2. There was no indication of any further issues, just lengthy tests for the selection of the final formula to be used, remembering that this is the formula they hope to use for Phase 3.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.